Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Allan JM, Travis LB . Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005; 5: 943–955.

    Article  CAS  PubMed  Google Scholar 

  2. Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003; 9: 3012–3020.

    CAS  PubMed  Google Scholar 

  3. Zhu YM, Das-Gupta EP, Russell NH . Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood 1999; 94: 733–740.

    CAS  PubMed  Google Scholar 

  4. Ross DD, Chen SR, Cuddy DP . Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer Res 1990; 50: 2658–2666.

    CAS  PubMed  Google Scholar 

  5. Arnaudeau C, Lundin C, Helleday T . DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 2001; 307: 1235–1245.

    Article  CAS  PubMed  Google Scholar 

  6. Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, Boothman DA . DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 2005; 280: 5516–5526.

    Article  CAS  PubMed  Google Scholar 

  7. Takahashi T, Min Z, Uchida I, Arita M, Watanabe Y, Koi M et al. Hypersensitivity in DNA mismatch repair-deficient colon carcinoma cells to DNA polymerase reaction inhibitors. Cancer Lett 2005; 220: 85–93.

    Article  CAS  PubMed  Google Scholar 

  8. Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002; 20: 3878–3884.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Leukemia and Lymphoma Research, UK (Grant no. 06002 to JMA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Allan.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fordham, S., Matheson, E., Scott, K. et al. DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs. Leukemia 25, 1046–1049 (2011). https://doi.org/10.1038/leu.2011.38

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.38

This article is cited by

Search

Quick links